Crossmark

Food addiction: a valid concept?

Crossref DOI link: https://doi.org/10.1038/s41386-018-0203-9

Published Online: 2018-09-06

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fletcher, Paul C.

Kenny, Paul J.
License Information

Text and Data Mining valid from 2018-09-06
More Information

Article History

Received: 22 June 2018

Revised: 12 August 2018

Accepted: 15 August 2018

First Online: 6 September 2018

Change Date: 7 December 2018

Change Type: Correction

Change Details: This article was originally published under standard licence, but has now been made available under a [CC BY 4.0] license. The PDF and HTML versions of the paper have been modified accordingly.

Competing interests

: PJK is a co-founder and shareholder in Eolas Therapeutics Inc., has a patent license agreement with AstraZeneca, receives research support from Eli Lilly, and has received consulting fees from Takenda Pharmaceuticals, USA. PCF has received consulting fees from GlaxoSmithKline.